Why Are People Selling Their ARCE Shares?

Arco Platform stock is trading -38.1% below its average target price of $18.06 after dropping -9.7% during today's morning session. Analysts are giving the small-cap Health Industry Service company an average rating of buy and target prices ranging from $17.0 to $20.99 per share.

Arco Platform's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 5.0%. The stock's short ratio is 43.75. At 1.02%, the company's rate of insider ownership does not indicate that management is deeply invested in the company.

Another number to watch is the company's rate of institutional share ownership, which now stands at 88.5%.

Institutions Invested in Arco Platform

Date Reported Holder Percentage Shares Value
2022-12-31 Keenan Capital, LLC 16% 4,735,445 $52,942,276
2022-12-31 Wishbone Management, LP 10% 2,895,932 $32,376,520
2022-12-31 Capital Research Global Investors 9% 2,711,223 $30,311,473
2022-12-31 Arisaig Partners (asia) Pte Ltd. 8% 2,264,964 $25,322,298
2022-12-31 Price (T.Rowe) Associates Inc 8% 2,257,627 $25,240,270
2022-12-31 Dragoneer Investment Group, LLC 5% 1,565,395 $17,501,116
2022-12-31 General Atlantic, L.P. 4% 1,183,934 $13,236,382
2022-12-31 Truxt Investmentos Ltda 4% 1,162,030 $12,991,495
2022-12-31 Tekne Capital Management, LLC 2% 661,822 $7,399,170
2022-12-31 Credit Suisse Ag/ 2% 632,813 $7,074,849
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.